LOCAMETZ

This brand name is authorized in Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Romania, United States

Active ingredients

The drug LOCAMETZ contains one active pharmaceutical ingredient (API):

1 Gozetotide UNII ZJ0EKR6M10 - GALLIUM GA-68 GOZETOTIDE

Read about Gallium ⁶⁸Ga gozetotide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LOCAMETZ Kit for radiopharmaceutical preparation	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V09IX14		V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IX Other diagnostic radiopharmaceuticals for tumour detection
Discover more medicines within V09IX14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1891953
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1221692001
Country: FR	Base de données publique des médicaments	Identifier(s): 67475965
Country: IT	Agenzia del Farmaco	Identifier(s): 050420013
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1096124
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69481001
Country: US	FDA, National Drug Code	Identifier(s): 69488-017